Article
Protection against RNA-induced liver damage by myeloid cells requires type I interferon and IL-1 receptor antagonist in mice.
Hepatology (Baltimore, Md.) - 1 Apr 2014
Conrad Elea, Resch Theresa K, Gogesch Patricia, Kalinke Ulrich, Bechmann Ingo, Bogdan Christian, Waibler Zoe
Abstract excerpt
UNLABELLED: Cell types and mechanisms involved in type I interferon (IFN)-mediated anti-inflammatory effects are poorly understood. Upon injection of artificial double-stranded RNA (poly(I:C)), we observed severe liver damage in type I IFN-receptor (IFNAR) chain 1-deficient mice, but not in wild-...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
